|
1.
|
Poon RT, Fan ST, Tsang FH and Wong J:
Locoregional therapies for hepatocellular carcinoma: a critical
review from the surgeon’s perspective. Ann Surg. 235:466–486.
2002.PubMed/NCBI
|
|
2.
|
Witzigmann H, Geissler F, Benedix F, et
al: Prospective evaluation of circulating hepatocytes by
alpha-fetoprotein messenger RNA in patients with hepatocellular
carcinoma. Surgery. 131:34–43. 2002. View Article : Google Scholar
|
|
3.
|
Lemoine A, Le Bricon T, Salvucci M, et al:
Prospective evaluation of circulating hepatocytes by
alpha-fetoprotein mRNA in humans during liver surgery. Ann Surg.
226:43–50. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Kamiyama T, Takahashi M, Nakagawa T, et
al: AFP mRNA detected in bone marrow by real-time quantitative
RT-PCR analysis predicts survival and recurrence after curative
hepatectomy for hepatocellular carcinoma. Ann Surg. 244:451–463.
2006.PubMed/NCBI
|
|
5.
|
Morimoto O, Nagano H, Miyamoto A, et al:
Association between recurrence of hepatocellular carcinoma and
alpha-fetoprotein messenger RNA levels in peripheral blood. Surg
Today. 35:1033–1041. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Miyamoto A, Nagano H, Sakon M, et al:
Clinical application of quantitative analysis for detection of
hematogenous spread of hepatocellular carcinoma by real-time PCR.
Int J Oncol. 18:527–532. 2001.PubMed/NCBI
|
|
7.
|
Marubashi S, Dono K, Sugita Y, et al:
Alpha-fetoprotein mRNA detection in peripheral blood for prediction
of hepatocellular carcinoma recurrence after liver transplantation.
Transplant Proc. 38:3640–3642. 2006. View Article : Google Scholar
|
|
8.
|
Marubashi S, Dono K, Nagano H, et al:
Detection of AFP mRNA-expressing cells in the peripheral blood for
prediction of HCC recurrence after living donor liver
transplantation. Transpl Int. 20:576–582. 2007. View Article : Google Scholar
|
|
9.
|
Peng BG, He Q, Li JP and Zhou F: Adjuvant
transcatheter arterial chemoembolization improves efficacy of
hepatectomy for patients with hepatocellular carcinoma and portal
vein tumor thrombus. Am J Surg. 198:313–318. 2009. View Article : Google Scholar
|
|
10.
|
Sugo H, Futagawa S, Beppu T, Fukasawa M
and Kojima K: Role of pre-operative transcatheter arterial
chemoembolization for resectable hepatocellular carcinoma: relation
between postoperative course and the pattern of tumor recurrence.
World J Surg. 27:1295–1299. 2003. View Article : Google Scholar
|
|
11.
|
Zhong C, Guo RP, Li JQ, et al: A
randomized controlled trial of hepatectomy with adjuvant
transcatheter arterial chemoembolization versus hepatectomy alone
for Stage III A hepatocellular carcinoma. J Cancer Res Clin Oncol.
135:1437–1445. 2009. View Article : Google Scholar
|
|
12.
|
Lu CD, Peng SY, Jiang XC, Chiba Y and
Tanigawa N: Pre-operative transcatheter arterial chemoembolization
and prognosis of patients with hepatocellular carcinomas:
retrospective analysis of 120 cases. World J Surg. 23:293–300.
1999. View Article : Google Scholar
|
|
13.
|
Di Carlo V, Ferrari G, Castoldi R, et al:
Pre-operative chemoembolization of hepatocellular carcinoma in
cirrhotic patients. Hepatogastroenterology. 45:1950–1954.
1998.PubMed/NCBI
|
|
14.
|
Majno PE, Adam R, Bismuth H, et al:
Influence of pre-operative transarterial lipiodol chemoembolization
on resection and transplantation for hepatocellular carcinoma in
patients with cirrhosis. Ann Surg. 226:688–703. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Harada T, Matsuo K, Inoue T, Tamesue S and
Nakamura H: Is preoperative hepatic arterial chemoembolization safe
and effective for hepatocellular carcinoma? Ann Surg. 224:4–9.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Gerunda GE, Neri D, Merenda R, et al: Role
of transarterial chemoembolization before liver resection for
hepatocarcinoma. Liver Transpl. 6:619–626. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Imaoka S, Sasaki Y, Shibata T, et al: A
pre-operative chemoembolization therapy using lipiodol, cisplatin
and gelatin sponge for hepatocellular carcinoma. Cancer Chemother
Pharmacol. 23:S126–S128. 1989. View Article : Google Scholar
|
|
18.
|
Adachi E, Matsumata T, Nishizaki T,
Hashimoto H, Tsuneyoshi M and Sugimachi K: Effects of pre-operative
transcatheter hepatic arterial chemoembolization for hepatocellular
carcinoma. The relationship between postoperative course and tumor
necrosis. Cancer. 72:3593–3598. 1993. View Article : Google Scholar
|
|
19.
|
Zhang Z, Liu Q, He J, Yang J, Yang G and
Wu M: The effect of pre-operative transcatheter hepatic arterial
chemoembolization on disease-free survival after hepatectomy for
hepatocellular carcinoma. Cancer. 89:2606–2612. 2000. View Article : Google Scholar
|
|
20.
|
Wu CC, Ho YZ, Ho WL, Wu TC, Liu TJ and
P’Eng FK: Pre-operative transcatheter arterial chemoembolization
for resectable large hepatocellular carcinoma: a reappraisal. Br J
Surg. 82:122–126. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Yamasaki S, Hasegawa H, Kinoshita H, et
al: A prospective randomized trial of the preventive effect of
pre-operative transcatheter arterial embolization against
recurrence of hepatocellular carcinoma. Jpn J Cancer Res.
87:206–211. 1996. View Article : Google Scholar
|
|
22.
|
Zhou WP, Lai EC, Li AJ, et al: A
prospective, randomized, controlled trial of pre-operative
transarterial chemoembolization for resectable large hepatocellular
carcinoma. Ann Surg. 249:195–202. 2009. View Article : Google Scholar
|
|
23.
|
Monden M, Okamura J, Sakon M, et al:
Significance of transcatheter chemoembolization combined with
surgical resection for hepatocellular carcinomas. Cancer Chemother
Pharmacol. 23:S90–S95. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Paye F, Jagot P, Vilgrain V, Farges O,
Borie D and Belghiti J: Pre-operative chemoembolization of
hepatocellular carcinoma: a comparative study. Arch Surg.
133:767–772. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Sasaki A, Iwashita Y, Shibata K, Ohta M,
Kitano S and Mori M: Pre-operative transcatheter arterial
chemoembolization reduces long-term survival rate after hepatic
resection for resectable hepatocellular carcinoma. Eur J Surg
Oncol. 32:773–779. 2006. View Article : Google Scholar
|
|
26.
|
Choi GH, Kim DH, Kang CM, et al: Is
pre-operative transarterial chemoembolization needed for a
resectable hepatocellular carcinoma? World J Surg. 31:2370–2377.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Nagasue N, Galizia G, Kohno H, et al:
Adverse effects of pre-operative hepatic artery chemoembolization
for resectable hepatocellular carcinoma: a retrospective comparison
of 138 liver resections. Surgery. 106:81–86. 1989.
|
|
28.
|
Uchida M, Kohno H, Kubota H, et al: Role
of pre-operative transcatheter arterial oily chemoembolization for
resectable hepatocellular carcinoma. World J Surg. 20:326–331.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Lee KT, Lu YW, Wang SN, et al: The effect
of pre-operative transarterial chemoembolization of resectable
hepatocellular carcinoma on clinical and economic outcomes. J Surg
Oncol. 99:343–350. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Seldinger SI: Catheter replacement of the
needle in percutaneous arteriography; a new technique. Acta Radiol.
39:368–376. 1953. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Dindo D, Demartines N and Clavien PA:
Classification of surgical complications: a new proposal with
evaluation in a cohort of 6336 patients and results of a survey.
Ann Surg. 240:205–213. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Gross-Goupil M, Saffroy R, Azoulay D, et
al: Real-time quantification of AFP mRNA to assess hematogenous
dissemination after transarterial chemoembolization of
hepatocellular carcinoma. Ann Surg. 238:241–248. 2003. View Article : Google Scholar
|
|
33.
|
Jang MK, Lee HC, Kim IS, et al: Role of
additional angiography and chemoembolization in patients with
hepatocellular carcinoma who achieved complete necrosis following
transarterial chemoembolization. J Gastroenterol Hepatol.
19:1074–1080. 2004. View Article : Google Scholar
|
|
34.
|
Herber S, Biesterfeld S, Franz U, et al:
Correlation of multislice CT and histomorphology in HCC following
TACE: predictors of outcome. Cardiovasc Intervent Radiol.
31:768–777. 2008. View Article : Google Scholar : PubMed/NCBI
|
